ArticleNeuroimmunomodulation2026
<italic>Mycobacterium vaccae</italic> NCTC 11659 Attenuates Early Life Adversity-Induced Hippocampal Neuroinflammation in Mice.
Article in Neuroimmunomodulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionEarly life adversity (ELA) is a potent risk factor for negative mental health outcomes, in part through its enduring effects on neuroimmune function. The hippocampus is particularly sensitive to stress across the lifespan, and neuroinflammatory signaling has been implicated as a mediator linking a life stress history to vulnerability. Accordingly, we hypothesized that ELA, in particular when followed by chronic psychosocial stress during adulthood (CAS), would enhance expression of inflammatory genes in the hippocampus and that these effects would be ameliorated by intervention with Mycobacterium vaccae (M. vaccae), a soil-derived mycobacterium with immunoregulatory properties.
methodsTo test this, newborn male and female mice were exposed to the maternal separation (MS) paradigm between postnatal days (PNDs) 1-14 (i.e., 3h/day) before receiving repeated (3x) weekly (i.e., starting 1-2 weeks following weaning) subcutaneous (s.c.) administrations with sterile borate-buffered saline (BBS) as vehicle or a heat-killed preparation of M. vaccae NCTC (National Collection of Type Cultures) 11659 (0.1 mg/0.1 mL per s.c. injection) in sterile BBS. At the age of 7-8 weeks, CAS was induced in males by the chronic subordinate colony housing (CSC) paradigm and in females by the social instability paradigm (SIP), before all mice were euthanized and hippocampal tissue was isolated by micropunch for RNA extraction and quantitative PCR analysis of neuroinflammatory markers.
resultsAmong the panel of genes assessed, ELA significantly increased hippocampal expression of Iba1, CCL2, and IL-1β in vehicle- but not M. vaccae NCTC 11659-administered male and female mice. Surprisingly, CAS exposure alone did not affect hippocampal gene expression and even abrogated the reported ELA-induced expression changes.
conclusionTogether, these findings highlight hippocampal neuroimmune pathways as a mechanism by which predominantly ELA shapes long-term vulnerability, and support M. vaccae NCTC 11659 as a promising strategy for mitigating ELA-induced neuroinflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.